Cannabis News

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the "Class Period"). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:  (1) Aurora had significantly overpaid for previous acquisitions and experienced degradation in certain assets, including its production facilities and inventory; (2) the Company's purported "business transformation plan" and cost reset failed to mitigate the foregoing issues; (3) accordingly, it was foreseeable that the Company would record significant goodwill and asset impairment charges; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than December 1, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

-------------------------------

Contact:
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
info@pawarlawgroup.com

Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Canopy Growth Announces Closing of Previously Announced Exchange Transaction

Retirement of Approximately $263 Million of Debt Strengthens Canopy Growth's Balance Sheet and Preserves Cash to Support Future Growth

Canopy Growth Corporation (" Canopy Growth " or the " Company ") (TSX: WEED) (NASDAQ: CGC) announced today that it has closed (the " Final Closing ") its previously announced exchange transaction (the " Transaction ") of certain 4.25% unsecured notes due 2023 (the " Notes ") in order to reduce its debt obligations by approximately $263 million . Constellation Brands, Inc. (" CBI "), through its wholly-owned subsidiary Greenstar Canada Investment Limited Partnership (" GCILP "), participated in the Transaction.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
US flag

Cannabis Weekly Round-Up: US Legalization Push Causes Stock Run

Cannabis market participants learned this past week about another potential legalization bill that is set to make an appearance in the US. Stocks rose in response to this long-shot attempt at reform.

In Canada, there’s an increasing challenge in retaining budtenders at cannabis dispensaries across the nation.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (" Cresco Labs " or the " Company "), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, conducted its annual and special meeting of shareholders (the " Meeting ") today, July 15, 2022 at 10:00 a.m. (Central Time).

At the Meeting, the number of directors on the board of directors of the Company for the ensuing year was fixed at eleven (11) by the shareholders and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the Meeting:

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Columbia Care Obtains Final Order of the Supreme Court of British Columbia Approving Business Combination with Cresco Labs

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) ("Columbia Care" or the "Company"), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced today that it has obtained the final order from the Supreme Court of British Columbia approving the previously announced plan of arrangement (the "Arrangement"), whereby, among other things, Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs") will acquire all of the issued and outstanding shares of the Company.

The final order follows on achieving overwhelming shareholder approval for the business combination at the special meeting of shareholders of the Company held on July 8, 2022.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Green Thumb Industries Announces Exercise of Extended Maturity Date of Senior Debt Facility

Green Thumb Industries Inc. ("Green Thumb") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE dispensaries today announced it has exercised its right to extend the maturity date of its senior non-brokered debt by one year, from April 30, 2024 to April 30, 2025.

The current senior secured notes (the "Notes"), which have a total principal amount of approximately $250 million, bear interest at a rate of 7% per annum and is paid quarterly. The extended maturity date did not involve any amendments to the Notes or any additional consideration to the existing lenders.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2022 second quarter earnings conference call on Tuesday, August 9, 2022 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×